CNTA CENTESSA PHARMACEUTICALS PLC Investments/Divestments 8-K Filing 2023 - Data Presentation and Press Release Centessa Pharmaceuticals shared data from a Phase 2a study of SerpinPC at the ASH Annual Meeting and issued a press release with new data on the treatment of Hemophilia.Get access to all SEC 8-K filings of the CENTESSA PHARMACEUTICALS PLC